- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Dove launches new bone densitometer
Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a
Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a singlebutton, according to the Newbury Park, CA, company.
Earlier this year, Dove signed a deal with Merck in which thatpharmaceutical firm will provide equipment financing support forphysicians purchasing Dove bone densitometers. Merck, which ismarketing its Fosamax drug for the treatment of osteoporosis,has signed similar deals with a number of other bone densitometryvendors (SCAN 2/14/96 and 7/6/95).
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
